Evidence map›Paper›PMID 34285201›Full record

ArticleHuman genome variation2021

Hyperprolinemia type I caused by homozygous p.T466M mutation in PRODH.

Rina Hama, Jun Kido, Keishin Sugawara, Toshiro Nakamura, Kimitoshi Nakamura

Open access · goldAbstract read
In one paragraph

Article in Human genome variation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. CoQExperimental & molecular medicine · 2026
    Review
  2. Article
  3. Review
  4. Myoclonus-Ataxia Syndrome Associated with Hyperprolinemia Type I.Movement disorders clinical practice · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rina HamaDepartment of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan.
Jun KidoDepartment of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan. kidojun@kuh.kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0003-1328-6696
Keishin SugawaraDepartment of Pediatrics, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Toshiro NakamuraDepartment of Pediatrics, Kumamoto Chuo Hospital, Kumamoto, Japan.
Kimitoshi NakamuraDepartment of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan.
Kumamoto University Hospital · JPKumamoto University · JPSaiseikai Kumamoto Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperprolinemia type I (HPI) is an autosomal recessive metabolic disorder caused by defects in proline oxidase. We herein describe a case of a patient with HPI and harboring the NM_016335.4 (PRODH_v001):c.1397 C > T (p.T466M) mutation and polymorphisms in the PRODH gene, as detected by plasma amino acid analysis and Sanger sequencing. The patient presented with short stature, carbohydrate-rich dietary preferences, and mild intellectual disability that was suggestive of a neurodevelopmental or learning disorder.

Identifiers

PMID34285201
PMCPMC8292323
OpenAlexW3185530622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.